Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.31 |
| ▸ | GCK | P35557 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL950557 | 0.93 | DHODH (0.33) | DHODHCYP17A1CYP1A2POLBTRPV1 | |
| SCHEMBL12912130 | 0.91 | DHODH (0.34) | DHODHCYP17A1CYP1A2 | |
| SCHEMBL12528160 | 0.90 | RAB9A (0.35) | DHODHCYP17A1CYP1A2SLC40A1PARP1 | |
| SCHEMBL12528553 | 0.88 | DHODH (0.35) | DHODHCYP17A1CYP1A2SLC40A1PARP1 | |
| SCHEMBL12528168 | 0.88 | DHODH (0.43) | DHODHCYP17A1CYP1A2SLC40A1PARP1 | |
| SCHEMBL12528926 | 0.86 | DHODH (0.33) | DHODHCYP17A1CYP1A2SLC40A1PARP1 | |
| SCHEMBL12528180 | 0.85 | CYP17A1 (0.37) | DHODHCYP17A1CYP1A2SLC40A1PARP1 | |
| SCHEMBL12528591 | 0.85 | DHODH (0.34) | DHODHCYP17A1CYP1A2SLC40A1PIK3CD | |
| SCHEMBL12528578 | 0.85 | SLC40A1 (0.36) | DHODHCYP17A1CYP1A2SLC40A1PIK3CD | |
| SCHEMBL12528568 | 0.85 | MEN1 (0.34) | DHODHCYP17A1CYP1A2SLC40A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7867949-B2 | Hydrazide compound and pesticidal use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20090181956-A1 | Hydrazide Compound and Pesticidal Use of the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181956-A1 | Hydrazide Compound and Pesticidal Use of the Same | ACHE, DDT, CAT | DHODH 284/4885CYP17A1 1452/4885CYP1A2 504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.